XML 27 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Oct. 31, 2011
Oct. 31, 2010
Cash flows from operating activities    
Net income $ 44,600 $ 44,350
Adjustments to reconcile net income to net cash used by operating activities:    
Depreciation and amortization 5,251 4,065
Equity based compensation 3,616 2,423
Tax benefit from exercise/vesting of equity awards 746  
Deferred financing charges 365 664
Equity in loss of joint venture 812  
Changes in operating assets and liabilities:    
Accounts receivable, net (229,746) (223,645)
Inventories (68,166) (88,630)
Income taxes, net 24,031 17,358
Prepaid expenses and other current assets 648 4,022
Other assets, net 103 (1,084)
Accounts payable, accrued expenses and other liabilities (4,459) 51,347
Net cash used in operating activities (222,199) (189,130)
Cash flows from investing activities    
Investment in equity of joint venture (3,350)  
Capital expenditures (12,937) (14,513)
Net cash used in investing activities (16,287) (14,513)
Cash flows from financing activities    
Proceeds from notes payable, net 245,058 166,739
Proceeds from exercise of equity awards 516 2,518
Stock repurchase (2,929)  
Excess tax benefit from exercise/vesting of equity awards 1,957 4,166
Net cash provided by financing activities 244,602 173,423
Effect of exchange rate changes (78) (7)
Net increase / (decrease) in cash and cash equivalents 6,038 (30,227)
Cash and cash equivalents at beginning of period 10,045 46,813
Cash and cash equivalents at end of period 16,083 16,586
Cash paid during the period for:    
Interest 3,364 2,651
Income taxes $ 1,134 $ 7,404